BRIEF-Zynerba provides clinical update for lead development candidates - ZYN001 and ZYN002
October 17, 2016 at 07:13 AM EDT
* Zynerba Pharmaceuticals Inc - topline results for three phase 2 clinical trials for ZYN002 are on track for 1h17
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|